This inventor holds 1 USPTO granted patent and 1 published patent application and 6 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Christian Kramer: Innovator in Pharmaceutical Chemistry
Introduction
Christian Kramer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on imidazole-pyrazole derivatives. His research focuses on developing compounds that can serve as effective medicaments, especially in combating bacterial infections.
Latest Patents
Christian Kramer holds a patent for imidazole-pyrazole derivatives, which are described by the general formula (I). This patent includes pharmaceutically acceptable salts of these compounds. The disclosure outlines pharmaceutical compositions that incorporate these derivatives, along with processes for manufacturing them. Furthermore, it details methods for using these compounds as antibiotics, aimed at treating or preventing bacterial infections and related diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Christian Kramer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His work in these organizations has allowed him to contribute to significant advancements in drug development and pharmaceutical research.
Collaborations
Christian has collaborated with esteemed colleagues in his field, including Jean-Baptiste Blanc and Christian D. Lerner. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Christian Kramer is a distinguished inventor whose work on imidazole-pyrazole derivatives has the potential to impact the treatment of bacterial infections significantly. His contributions to pharmaceutical chemistry exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
